Fundz

Luma Cyte, Inc. reported raising $1.25 Million in an initial SEC Form D filing, from an offering of $1.25 Million

PRIVATEMay 17, 2022

Amount Raised

$1.25 Million

$1.25 Million sold, per SEC Form D (first sale May 17, 2022)

Round Type

Seed

CharlottesvilleBiotechnology

Who to call at LumaCyte, Inc., and when

A new round usually means LumaCyte, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day LumaCyte, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at LumaCyte, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at LumaCyte, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

LumaCyte, Inc.

Location

1145 RIVER ROAD

Charlottesville, Virginia, United States

About

LumaCyte is an advanced research and bioanalytics instrumentation company that produces label-free, single cell analysis instrumentation where the use of antibody or genetic labeling is not required for cellular analysis. This revolutionary technology utilizes Laser Force Cytology™ (LFC™) to measure optical and fluidic forces within a microfluidic channel to identify and measure the intrinsic cellular properties of each cell. The multivariate nature of the data has enabled a host of Big Data strategies and cloud computing capabilities that drive advanced analytics, allowing a deeper understanding of cell based biological systems. Applications of LumaCyte's label-free platform technology include viral infectivity for vaccine development and manufacturing, cell and gene therapy development and production monitoring, cancer biology R&D, CAR T-cell immunotherapy, iPSCs, infectious disease, and pre-clinical drug discovery, in addition to multiple applications across the biomanufacturing sector for improved production consistency and product quality. Innovate. Discover. Transform.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment LumaCyte, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsSean H., Executive Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for LumaCyte, Inc.'s next move

See what Strategic adds

LumaCyte, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.